AGENUS INC Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
AGENUS INC (AGEN) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $98.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-16
- AGENUS INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $98.00K, a 82.75% decline from fiscal 2024.
- AGENUS INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $568.00K, a 35.09% decline from fiscal 2023.
- AGENUS INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $875.00K.
- AGENUS INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$3.26M.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $98.00K 10-K · filed 2026-03-16 | |
| 2024-12-31 | $568.00K 10-K · filed 2026-03-16 | $1.65M 10-K · filed 2025-03-17 |
| 2023-12-31 | $875.00K 10-K · filed 2026-03-16 | $1.19M 10-K · filed 2024-03-14 |
| 2022-12-31 | -$3.26M 10-K · filed 2025-03-17 | |
| 2021-12-31 | -$2.65M 10-K · filed 2024-03-14 | -$2.08M 10-K · filed 2022-03-01 |
| 2020-12-31 | -$3.74M 10-K · filed 2023-03-16 | |
| 2019-12-31 | $9.40M 10-K · filed 2022-03-01 | $10.77M 10-K · filed 2020-03-16 |
| 2018-12-31 | $5.51M 10-K · filed 2021-03-16 | $9.45M 10-K · filed 2019-03-18 |
| 2017-12-31 | $3.70M 10-K · filed 2020-03-16 | $2.62M 10-K · filed 2018-03-16 |
| 2016-12-31 | $6.57M 10-K · filed 2019-03-18 | |
| 2015-12-31 | $4.35M 10-K · filed 2018-03-16 | |
| 2014-12-31 | -$795.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $143.00K 10-K · filed 2016-03-15 | |
| 2012-12-31 | $640.00K 10-K · filed 2015-03-16 | |
| 2011-12-31 | -$169.00K 10-K · filed 2014-03-07 | |
| 2010-12-31 | $795.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |